Trding, I thought that was interesting also. I wonder if this is the case.....I think the PR from this morning didn’t specify combo HIV BLA.....it was stated as “Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)”.
Could this end up being one BLA submission?
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.